Friday, August 20, 2010

Bought C&O Pharmaceutical Technology today

I made yet another shares purchase today and this time round, the company picked was C&O Pharmaceutical Technology Limited [E92.SI].

The main reason why I bought this C&O is due to impressive to-come dividends. As anticipated by Philip Research, 4Q dividend could be at S$0.012 which makes the whole year dividend to be at S$0.08. If we were to use today's S$0.47/share, it would be 17%! This very healthy net cash comes after they sold Hong kong asset, which add to their EPS.

1 past dividend and 1 coming soon

Ex Date: 26 Aug 2010 SGD 0.028
Ex Date: 12 Jul 2010 SGD 0.005
Ex Date: 12 Jul 2010 SGD 0.035

This China-based drug maker's strong R&D capability provides springboard to launch new products, paving way for expansion in local and international markets. According to CIMB analyst, C&O is also an attractive partner to foreign drug companies looking to enter the China market.

Stay invested for the dividends remain my key investment strategy.

No comments:

Post a Comment

Do provide your constructive comment. I appreciate that.